250 related articles for article (PubMed ID: 18460397)
1. Differential expression of PTEN-targeting microRNAs miR-19a and miR-21 in Cowden syndrome.
Pezzolesi MG; Platzer P; Waite KA; Eng C
Am J Hum Genet; 2008 May; 82(5):1141-9. PubMed ID: 18460397
[TBL] [Abstract][Full Text] [Related]
2. Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations.
Yehia L; Ni Y; Sesock K; Niazi F; Fletcher B; Chen HJL; LaFramboise T; Eng C
PLoS Genet; 2018 Apr; 14(4):e1007352. PubMed ID: 29684080
[TBL] [Abstract][Full Text] [Related]
3. Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway.
Zhou XP; Waite KA; Pilarski R; Hampel H; Fernandez MJ; Bos C; Dasouki M; Feldman GL; Greenberg LA; Ivanovich J; Matloff E; Patterson A; Pierpont ME; Russo D; Nassif NT; Eng C
Am J Hum Genet; 2003 Aug; 73(2):404-11. PubMed ID: 12844284
[TBL] [Abstract][Full Text] [Related]
4. Distinct expression profiles for PTEN transcript and its splice variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome.
Sarquis MS; Agrawal S; Shen L; Pilarski R; Zhou XP; Eng C
Am J Hum Genet; 2006 Jul; 79(1):23-30. PubMed ID: 16773562
[TBL] [Abstract][Full Text] [Related]
5. Germline PTEN, SDHB-D, and KLLN alterations in endometrial cancer patients with Cowden and Cowden-like syndromes: an international, multicenter, prospective study.
Mahdi H; Mester JL; Nizialek EA; Ngeow J; Michener C; Eng C
Cancer; 2015 Mar; 121(5):688-96. PubMed ID: 25376524
[TBL] [Abstract][Full Text] [Related]
6. Mutation-positive and mutation-negative patients with Cowden and Bannayan-Riley-Ruvalcaba syndromes associated with distinct 10q haplotypes.
Pezzolesi MG; Li Y; Zhou XP; Pilarski R; Shen L; Eng C
Am J Hum Genet; 2006 Nov; 79(5):923-34. PubMed ID: 17033968
[TBL] [Abstract][Full Text] [Related]
7. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome.
Marsh DJ; Kum JB; Lunetta KL; Bennett MJ; Gorlin RJ; Ahmed SF; Bodurtha J; Crowe C; Curtis MA; Dasouki M; Dunn T; Feit H; Geraghty MT; Graham JM; Hodgson SV; Hunter A; Korf BR; Manchester D; Miesfeldt S; Murday VA; Nathanson KL; Parisi M; Pober B; Romano C; Eng C
Hum Mol Genet; 1999 Aug; 8(8):1461-72. PubMed ID: 10400993
[TBL] [Abstract][Full Text] [Related]
8. Bannayan-Riley-Ruvalcaba syndrome: further delineation of the phenotype and management of PTEN mutation-positive cases.
Hendriks YM; Verhallen JT; van der Smagt JJ; Kant SG; Hilhorst Y; Hoefsloot L; Hansson KB; van der Straaten PJ; Boutkan H; Breuning MH; Vasen HF; Bröcker-Vriends AH
Fam Cancer; 2003; 2(2):79-85. PubMed ID: 14574156
[TBL] [Abstract][Full Text] [Related]
9. Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers.
Lachlan KL; Lucassen AM; Bunyan D; Temple IK
J Med Genet; 2007 Sep; 44(9):579-85. PubMed ID: 17526800
[TBL] [Abstract][Full Text] [Related]
10. Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53.
Ni Y; He X; Chen J; Moline J; Mester J; Orloff MS; Ringel MD; Eng C
Hum Mol Genet; 2012 Jan; 21(2):300-10. PubMed ID: 21979946
[TBL] [Abstract][Full Text] [Related]
11. Cowden syndrome.
Gustafson S; Zbuk KM; Scacheri C; Eng C
Semin Oncol; 2007 Oct; 34(5):428-34. PubMed ID: 17920899
[TBL] [Abstract][Full Text] [Related]
12. PTEN: one gene, many syndromes.
Eng C
Hum Mutat; 2003 Sep; 22(3):183-98. PubMed ID: 12938083
[TBL] [Abstract][Full Text] [Related]
13. Comparative genomic and functional analyses reveal a novel cis-acting PTEN regulatory element as a highly conserved functional E-box motif deleted in Cowden syndrome.
Pezzolesi MG; Zbuk KM; Waite KA; Eng C
Hum Mol Genet; 2007 May; 16(9):1058-71. PubMed ID: 17341483
[TBL] [Abstract][Full Text] [Related]
14. Thyroid pathology in PTEN-hamartoma tumor syndrome: characteristic findings of a distinct entity.
Laury AR; Bongiovanni M; Tille JC; Kozakewich H; Nosé V
Thyroid; 2011 Feb; 21(2):135-44. PubMed ID: 21190448
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
Ngeow J; Sesock K; Eng C
Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
[TBL] [Abstract][Full Text] [Related]
16. Germline mutations in the PTEN gene in Israeli patients with Bannayan-Riley-Ruvalcaba syndrome and women with familial breast cancer.
Figer A; Kaplan A; Frydman M; Lev D; Paswell J; Papa MZ; Goldman B; Friedman E
Clin Genet; 2002 Oct; 62(4):298-302. PubMed ID: 12372056
[TBL] [Abstract][Full Text] [Related]
17. PTEN hamartoma tumor syndromes in childhood: description of two cases and a proposal for follow-up protocol.
Piccione M; Fragapane T; Antona V; Giachino D; Cupido F; Corsello G
Am J Med Genet A; 2013 Nov; 161A(11):2902-8. PubMed ID: 24123798
[TBL] [Abstract][Full Text] [Related]
18. Imaging of PTEN-related abnormalities in the central nervous system.
Dhamija R; Hoxworth JM
Clin Imaging; 2020 Apr; 60(2):180-185. PubMed ID: 31927175
[TBL] [Abstract][Full Text] [Related]
19. Distinct Alterations in Tricarboxylic Acid Cycle Metabolites Associate with Cancer and Autism Phenotypes in Cowden Syndrome and Bannayan-Riley-Ruvalcaba Syndrome.
Yehia L; Ni Y; Feng F; Seyfi M; Sadler T; Frazier TW; Eng C
Am J Hum Genet; 2019 Oct; 105(4):813-821. PubMed ID: 31564436
[TBL] [Abstract][Full Text] [Related]
20. Utility of PTEN protein dosage in predicting for underlying germline PTEN mutations among patients presenting with thyroid cancer and Cowden-like phenotypes.
Ngeow J; He X; Mester JL; Lei J; Romigh T; Orloff MS; Milas M; Eng C
J Clin Endocrinol Metab; 2012 Dec; 97(12):E2320-7. PubMed ID: 23066114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
